Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice
Open Access
- 15 December 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 132 (24)
Abstract
The lymph node (LN) is the primary site of alloimmunity activation and regulation during transplantation. Here, we investigated how fibroblastic reticular cells (FRCs) facilitate the tolerance induced by anti-CD40L in a murine model of heart transplantation. We found that both the absence of LNs and FRC depletion abrogated the effect of anti-CD40L in prolonging murine heart allograft survival. Depletion of FRCs impaired homing of T cells across the high endothelial venules (HEVs) and promoted formation of alloreactive T cells in the LNs in heart-transplanted mice treated with anti-CD40L. Single-cell RNA sequencing of the LNs showed that anti-CD40L promotes a Madcam1+ FRC subset. FRCs also promoted the formation of regulatory T cells (Tregs) in vitro. Nanoparticles (NPs) containing anti-CD40L were selectively delivered to the LNs by coating them with MECA-79, which binds to peripheral node addressin (PNAd) glycoproteins expressed exclusively by HEVs. Treatment with these MECA-79–anti-CD40L-NPs markedly delayed the onset of heart allograft rejection and increased the presence of Tregs. Finally, combined MECA-79–anti-CD40L-NPs and rapamycin treatment resulted in markedly longer allograft survival than soluble anti-CD40L and rapamycin. These data demonstrate that FRCs are critical to facilitating costimulatory blockade. LN-targeted nanodelivery of anti-CD40L could effectively promote heart allograft acceptance.Keywords
This publication has 142 references indexed in Scilit:
- Regulatory T cell migration during an immune responseTrends in Immunology, 2012
- Targeted polymeric therapeutic nanoparticles: design, development and clinical translationChemical Society Reviews, 2012
- Innate immunity alone is not sufficient for chronic rejection but predisposes healed allografts to T cell-mediated pathologyTransplant Immunology, 2012
- Antigen-specific induced Foxp3+regulatory T cells are generated following CD40/CD154 blockadeProceedings of the National Academy of Sciences, 2011
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJAMA, 2011
- Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated InflammationImmunity, 2011
- Novel Anti-carbohydrate Antibodies Reveal the Cooperative Function of Sulfated N- and O-Glycans in Lymphocyte HomingJournal of Biological Chemistry, 2010
- Subcellular targeting strategies for drug design and deliveryNature Reviews Drug Discovery, 2010
- Distinct regulatory roles of transforming growth factor‐β and interleukin‐4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cellsImmunology, 2009
- How regulatory T cells workNature Reviews Immunology, 2008